|
US2018153889A1
|
|
Modulation of cell fates and activities by phthalazinediones
|
|
WO2017117586A1
|
|
Compositions and nethods for treating brain dysfunction
|
|
WO2014145472A2
|
|
A method for treating neurodegeneration using a p38mapk inhibitor
|
|
AU2013201111A1
|
|
Modulation of cell fates and activities by phthalazinediones
|
|
WO2010096686A1
|
|
Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
|
|
WO2010091257A1
|
|
Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
|
|
AU2009296743A1
|
|
Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and NRF2 transcription factors
|
|
US2005288291A1
|
|
Modulation of cell fates and activities by phthalazinediones
|
|
US6953799B1
|
|
Modulation of cell fates and activities by diketo phthalazines
|
